Over a year has passed since COVID-19 took center stage in our lives. I think we can all agree that every week, things get a little less scary. Life is slowly getting back to normal as vaccine distribution continues to ramp up and appointments become less scarce. While it seems like everything is moving in the right direction, COVID research is still as critical today as it was a year ago. Here are some reasons why.
Emergency Use Authorization (EUA) vs. Full FDA Approval
Right now, there is only 1 treatment fully approved for use in treating COVID-19; Remdesivir. All other therapies, diagnostic tests, vaccines, and medical devices currently being used are under Emergency Use Authorizations (EUAs). EUAs are when the FDA allows the availability and use of certain therapies including vaccines, in emergencies like a pandemic.
Rather than wait until the trials are complete, which can take many years, the FDA reviews data collected thus far and decides if the therapy can be used and, if so, under what restrictions. Even with EUA, trials for these therapies continue until completed and full FDA approval is granted. Continued research is also vital to the discovery and evaluation of other ways to detect, treat, and prevent COVID-19.
89% Scientists Believe SARS-CoV-2 Will Become an Endemic
Though eradication of COVID could happen in some more remote areas, 89% of scientists surveyed believe that it’s here to stay, much like the flu. To add, this is a new virus, and we are still learning about it. Time needs to pass to see the impact of long-term health complications and more work needs to be done on variants to evaluate their effects on vaccines, treatments, etc.
Five years from now, a child at daycare will catch the same virus that took the lives of almost 30 million people globally. The child won’t experience anything more than mild symptoms and will recover quickly. Clinical research is the pathway to that certainty. By participating in clinical research studies, you can help advance medicine and the future health of generations to come.
Clinical Site Partners still needs participants to join ongoing COVID-19 studies. To learn more, call (407) 740-8078 or visit our website.